Skip to content

SLR Trial

A Multicenter Randomized Controlled Trial on the Use of Staple Line Reinforcement in Pulmonary Sublobar Resection - SLR Trial: Staple Line Reinforcement in Pulmonary Sublobar Resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062250047
Enrollment
140
Registered
2025-08-27
Start date
2025-09-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary lung cancer, metastatic lung tumor, benign lung tumor, pneumothorax, etc.

Interventions

SLR use or non-use

Sponsors

Tanaka Yugo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria will be included: (1) Patients scheduled to undergo thoracoscopic pulmonary sublobar resection (wedge resection or segmentectomy) using an automatic stapler. * Thoracoscopic surgery includes robot-assisted thoracoscopic surgery. (2) Patients who have provided written informed consent for participation in this study.

Exclusion criteria

Exclusion criteria: **Exclusion Criteria for Initial Registration** Patients meeting any of the following criteria will be excluded from this clinical study: (1) Patients suspected of having severe intrathoracic adhesions (e.g., history of empyema, tuberculosis, or ipsilateral reoperation). (2) Patients deemed unsuitable as subjects by the principal investigator or sub-investigators. (3) Patients undergoing pulmonary resection at three or more sites simultaneously. **Exclusion Criteria for Secondary Registration** Patients meeting the following criterion will not proceed to secondary registration: (1) Patients for whom thoracoscopic surgery or the use of an automatic stapler was discontinued due to severe intrathoracic adhesions or other reasons.

Design outcomes

Primary

MeasureTime frame
The incidence of air leaks from the staple line during the intraoperative water-sealing test

Secondary

MeasureTime frame
(1) The incidence of air leaks at different pressure levels (2) Duration of air leaks (3) Location of air leaks (4) Duration of chest drain placement (5) Presence of respiratory complications within 30 days postoperatively (6) Presence of adverse events (7) Economic impact

Contacts

Public ContactShinji Matsui

Tottori University Hospital

s-matsui@tottori-u.ac.jp+81-859-38-6737

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026